Ishigami M - Search Results

1

Immunomodulatory Effects of Adipose Tissue-Derived Stem Cells on Concanavalin A-Induced Acute Liver Injury in Mice.

Yoshizumi Y, Yukawa H, Iwaki R, Fujinaka S, Kanou A, Kanou Y, Yamada T, Nakagawa S, Ohara T, Nakagiri K, Ogihara Y, Tsutsui Y, Hayashi Y, Ishigami M, Baba Y, Ishikawa T. Yoshizumi Y, et al. Among authors: ishigami m. Cell Med. 2016 Oct 6;9(1-2):21-33. doi: 10.3727/215517916X693159. eCollection 2017 Jan 8. Cell Med. 2016. PMID: 28174672 Free PMC article.

2

Use of the Model for End-Stage Liver Disease (MELD) score to predict 1-year survival of Japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantation.

Ishigami M, Honda T, Okumura A, Ishikawa T, Kobayashi M, Katano Y, Fujimoto Y, Kiuchi T, Goto H. Ishigami M, et al. J Gastroenterol. 2008;43(5):363-8. doi: 10.1007/s00535-008-2168-7. Epub 2008 Jul 1. J Gastroenterol. 2008. PMID: 18592154

3

Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapy.

Hayashi K, Katano Y, Honda T, Ishigami M, Itoh A, Hirooka Y, Ishikawa T, Nakano I, Yoshioka K, Toyoda H, Kumada T, Goto H. Hayashi K, et al. Among authors: ishigami m. Liver Int. 2011 Oct;31(9):1359-65. doi: 10.1111/j.1478-3231.2011.02571.x. Epub 2011 Jun 23. Liver Int. 2011. PMID: 21745312

4

Ursodeoxycholic acid inhibits overexpression of P-glycoprotein induced by doxorubicin in HepG2 cells.

Komori Y, Arisawa S, Takai M, Yokoyama K, Honda M, Hayashi K, Ishigami M, Katano Y, Goto H, Ueyama J, Ishikawa T, Wakusawa S. Komori Y, et al. Among authors: ishigami m. Eur J Pharmacol. 2014 Feb 5;724:161-7. doi: 10.1016/j.ejphar.2013.12.023. Epub 2013 Dec 24. Eur J Pharmacol. 2014. PMID: 24370495

5

Association of interleukin 28B polymorphism and mutations in the NS5A region of hepatitis C virus genotype 2 with interferon responsiveness.

Hayashi K, Katano Y, Ishizu Y, Kuzuya T, Honda T, Ishigami M, Itoh A, Hirooka Y, Ishikawa T, Nakano I, Yoshioka K, Toyoda H, Kumada T, Goto H. Hayashi K, et al. Among authors: ishigami m. J Gastroenterol Hepatol. 2015 Jan;30(1):178-83. doi: 10.1111/jgh.12673. J Gastroenterol Hepatol. 2015. PMID: 24995561

6

Hepatitis B e antigen and hepatitis B surface antigen seroclearance with the emergence of lamivudine-associated and core mutations following CD4 elevation in a patient with hepatitis B and HIV.

Honda T, Ishigami M, Luo F, Ishizu Y, Kuzuya T, Hayashi K, Itoh A, Hirooka Y, Ishikawa T, Nakano I, Katano Y, Goto H. Honda T, et al. Among authors: ishigami m. Intern Med. 2015;54(6):585-90. doi: 10.2169/internalmedicine.54.2038. Epub 2015 Jan 15. Intern Med. 2015. PMID: 25786446 Free article.

7

Endoscopic treatment of esophageal varices in hemophiliac patients with liver cirrhosis.

Ishizu Y, Ishigami M, Suzuki N, Kuzuya T, Honda T, Hayashi K, Katano Y, Hirooka Y, Ishikawa T, Matsushita T, Goto H. Ishizu Y, et al. Among authors: ishigami m. Gastrointest Endosc. 2015 Apr;81(4):1059-60. doi: 10.1016/j.gie.2014.11.043. Gastrointest Endosc. 2015. PMID: 25805492 No abstract available.

8

Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice.

Luo F, Ishigami M, Achiwa K, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Ishikawa T, Katano Y, Goto H. Luo F, et al. Among authors: ishigami m. Dig Dis Sci. 2015 Sep;60(9):2730-9. doi: 10.1007/s10620-015-3660-6. Epub 2015 Apr 14. Dig Dis Sci. 2015. PMID: 25868633

9

Early Clinical Response after 2 Weeks of Sorafenib Therapy Predicts Outcomes and Anti-Tumor Response in Patients with Advanced Hepatocellular Carcinoma.

Kuzuya T, Ishigami M, Ishizu Y, Honda T, Hayashi K, Katano Y, Hirooka Y, Ishikawa T, Nakano I, Goto H. Kuzuya T, et al. Among authors: ishigami m. PLoS One. 2015 Sep 30;10(9):e0138776. doi: 10.1371/journal.pone.0138776. eCollection 2015. PLoS One. 2015. PMID: 26421430 Free PMC article. Clinical Trial.

10

Fever within 2 Weeks of Sorafenib Therapy Predicts Favorable Treatment Efficacy in Patients with Advanced Hepatocellular Carcinoma.

Kuzuya T, Ishigami M, Ishizu Y, Honda T, Hayashi K, Ishikawa T, Nakano I, Goto H, Hirooka Y. Kuzuya T, et al. Among authors: ishigami m. Oncology. 2016;91(5):261-266. doi: 10.1159/000449000. Epub 2016 Sep 14. Oncology. 2016. PMID: 27622905

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

485 results

Search Page

Filters